Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM10 | O14672 | 20/20 | 0.49 |
| ▸ | MMP2 | P08253 | 18/20 | 0.49 |
| ▸ | MMP9 | P14780 | 10/20 | 0.49 |
| ▸ | MMP3 | P08254 | 5/20 | 0.49 |
| ▸ | MMP1 | P03956 | 3/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5042911 | 0.88 | ADAM10 (0.63) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL6023831 | 0.86 | ADAM10 (0.61) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5039259 | 0.85 | ADAM10 (0.64) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5042986 | 0.85 | ADAM10 (0.64) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5040167 | 0.85 | ADAM10 (0.50) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5038238 | 0.85 | ADAM10 (0.64) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5035155 | 0.84 | ADAM10 (0.63) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5039303 | 0.83 | ADAM10 (0.53) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5039619 | 0.82 | ADAM10 (0.61) | ADAM10MMP2MMP9MMP3MMP1 | |
| SCHEMBL5044734 | 0.82 | ADAM10 (0.61) | ADAM10MMP2MMP9MMP3MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2637679-A1 | ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS | The University of Chicago (US) | 2013-09-18 | — | — | EP | claimed |
| WO-2012064865-A1 | ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS | THE UNIVERSITY OF CHICAGO (US) | 2012-05-18 | — | — | WO | claimed |
| EP-2637679-A1 | ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS | The University of Chicago (US) | 2013-09-18 | — | — | EP | disclosed |
| WO-2012064865-A1 | ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS | THE UNIVERSITY OF CHICAGO (US) | 2012-05-18 | — | — | WO | disclosed |
| EP-1613269-A2 | COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE | Incyte Corporation (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004089294-A2 | COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE | INCYTE CORPORATION (US) | 2004-10-21 | — | — | WO | disclosed |